ConductScience.org, home

Paper11834837

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.

Di Croce L and 11 others. Science, 2002. Cited by 606 papers, by iCite.

Cite this record

ConductScience Library. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Papers, record 11834837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11834837

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
PubMed
Journal
Science
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
606
iCite
Relative citation ratio, by iCite
9.96
iCite
Revised in PubMed
2021-12-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Di Croce LLuciano
2Raker VAVeronica A
3Corsaro MMassimo
4Fazi FFrancesco
5Fanelli MMirco
6Faretta MMario
7Fuks FFrancois
8Lo Coco FFrancesco
9Kouzarides TTony
10Nervi CClara
11Minucci SSaverio
12Pelicci PGPier Giuseppe

Source PubMed

Download CSV of authors

Topics29

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzacitidineMajor topic
DNA (Cytosine-5-)-MethyltransferasesMajor topic
DNA MethylationMajor topic
Gene SilencingMajor topic
Neoplasm ProteinsMajor topic
Oncogene Proteins, FusionMajor topic
Promoter Regions, GeneticMajor topic
Receptors, Retinoic AcidMajor topic
Binding Sites
Cell Differentiation
Cell Line
Cell Nucleus
Cell Transformation, Neoplastic
Cloning, Molecular
CpG Islands
DNA (Cytosine-5-)-Methyltransferase 1
DNA Methyltransferase 3A
Decitabine
Exons
Gene Expression
Histone Deacetylases
Humans
Leukemia, Promyelocytic, Acute
Mutation
Recombinant Fusion Proteins
Transcription Factors
Tretinoin
Tumor Cells, Cultured
Zinc

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in11834787Cancer research. Leukemia protein spurs gene silencing.https://conductscience.org/library/papers/11834787PubMed
Comment in12229925Cancer epigenetics and methylation.https://conductscience.org/library/papers/12229925PubMed

Download CSV of comments and corrections

Cited by271

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 606 citations.

PMIDTitleJournalYearIn PapersSource
42856463Tumor suppressor-like mutations mark a dosage-constrained dependency in leukemia.bioRxiv2026https://conductscience.org/library/papers/42856463PubMed
39528729The N-terminal region of DNMT3A engages the nucleosome surface to aid chromatin recruitment.EMBO Rep2024https://conductscience.org/library/papers/39528729PubMed
39006906Emerging applications of hypomethylating agents in the treatment of glioblastoma (Review).Mol Clin Oncol2024https://conductscience.org/library/papers/39006906PubMed
38895633Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets.Front Pharmacol2024https://conductscience.org/library/papers/38895633PubMed
38696033Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors.Curr Treat Options Oncol2024https://conductscience.org/library/papers/38696033PubMed
38628758Epigenetic regulation of FOXI2 promotes clear cell renal cell carcinoma progression.Heliyon2024https://conductscience.org/library/papers/38628758PubMed
37569414The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients.Int J Mol Sci2023https://conductscience.org/library/papers/37569414PubMed
37568827YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.Cancers (Basel)2023https://conductscience.org/library/papers/37568827PubMed
37509198The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away.Cancers (Basel)2023https://conductscience.org/library/papers/37509198PubMed
36630129Characterizing crosstalk in epigenetic signaling to understand disease physiology.Biochem J2023https://conductscience.org/library/papers/36630129PubMed
36460706DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B.Sci Rep2022https://conductscience.org/library/papers/36460706PubMed
360602655-methylcytosine turnover: Mechanisms and therapeutic implications in cancer.Front Mol Biosci2022https://conductscience.org/library/papers/36060265PubMed
35999358Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis.Cancer Gene Ther2023https://conductscience.org/library/papers/35999358PubMed
35902872RUNX1T1 function in cell fate.Stem Cell Res Ther2022https://conductscience.org/library/papers/35902872PubMed
35808817mRNA expression and epigenetic-based role of chromodomain helicase DNA-binding 5 in hepatocellular carcinoma.J Int Med Res2022https://conductscience.org/library/papers/35808817PubMed
35450883In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of Klf4 in suppressing early leukemic transformation.Genes Dev2022https://conductscience.org/library/papers/35450883PubMed
35440061Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers.Epigenetics Chromatin2022https://conductscience.org/library/papers/35440061PubMed
35399865PML nuclear body biogenesis and oligomerization-driven leukemogenesis.Blood Sci2020https://conductscience.org/library/papers/35399865PubMed
35280824All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.Front Oncol2022https://conductscience.org/library/papers/35280824PubMed
35080973Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity.Sci Adv2022https://conductscience.org/library/papers/35080973PubMed

See all 271 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNMT11786PubTator's text mininghttps://conductscience.org/library/genes/1786NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
RARB5915PubTator's text mininghttps://conductscience.org/library/genes/5915NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11834837

GET https://conductscience.org/api/papers/v1/11834837/cited_by?page=2